Your First Month on a GLP-1 — A Week-by-Week Guide
What the first four weeks on Ozempic, Wegovy, Mounjaro or Zepbound tend to look like, week by week, and what to sort out before your first dose step.
Worth remembering
- Month one is usually the starting dose, which the labels say is for initiation, not the long-term dose.
- Stomach side effects are the most common reactions and often follow a pattern after each shot.
- Missed-dose windows differ by brand — 4 days for Mounjaro and Zepbound, 5 days for Ozempic, and a different rule for Wegovy.
- Tirzepatide labels add a contraception step for the first 4 weeks if you use oral birth control.
- Week four is for reviewing, not racing — the next step is your prescriber's call.
The pharmacy bag is on the counter. Inside is a pen, a leaflet folded smaller than seems possible, and a box that says 0.25 mg or 2.5 mg. You've read the forums. You know some people sail through the first month and others spend it near the kettle with ginger tea. What you don't know yet is which week will be which for you.
Here's how we'd think about the four weeks, one at a time.
Before the first shot: what's worth sorting out?
A few things are easier to settle before the pen touches skin.
- Pick a shot day you can keep. A calm evening beats a busy Monday morning.
- Read the Instructions for Use for your exact pen. Pens differ between brands.
- Know your brand's missed-dose rule. Mounjaro and Zepbound: within 4 days. Ozempic: within 5 days. Wegovy injection: take it if your next dose is more than 2 days away. Otherwise skip and carry on.
- Check your other medicines with your pharmacist. The labels warn that insulin or sulfonylureas raise the risk of low blood sugar. The tirzepatide labels also say oral birth control may work less well for a while, and advise a non-oral or added barrier method for 4 weeks after starting.
Week 1: what happens after the first dose?
For many people, not much. For others, fullness and queasiness arrive within a day or two. Both are normal starting points; the labels describe the first dose as the beginning of a ramp, and say the 2.5 mg tirzepatide dose isn't a maintenance dose at all.
Stomach side effects — nausea, diarrhea, vomiting, constipation — are the most commonly reported reactions on all four labels. The 2025 joint nutrition advisory suggests smaller meals, not going long stretches without eating, going easy on fatty foods, and keeping up fluids.
Week 2: is there a pattern yet?
Usually this is when it shows. Second shot, second set of days after — and you can start to compare. Did the queasiness arrive at the same point? Was it shorter this time?
That pattern is useful. "Days one and two after the shot, then fine" lets you plan meals, workouts and social plans around it, and it's exactly the kind of detail your prescriber asks about.
Week 3: are you eating enough of the right things?
By now appetite is often lower, and that's when protein, fiber and water quietly slip. The joint advisory names adequate protein (paired with strength training), fiber and hydration as core nutritional priorities during GLP-1 treatment.
Constipation often turns up around here too, especially if fluids and fiber have dropped. It's a common label side effect; tell your prescriber or pharmacist if it's bothering you rather than putting up with it.
Week 4: what happens at the end of the month?
The labels' usual rhythm is to consider the first step up after 4 weeks. Whether it happens then is up to your prescriber. The Wegovy label specifically says that if a dose isn't tolerated, delaying the next step by 4 weeks can be considered. We cover what the next stages look like in moving up a GLP-1 dose.
This is the week to look back rather than forward. Did side effects ease from week one to week four? Were there days you couldn't eat or drink much? Has your weight trend moved the way you and your prescriber expected? Those three answers make the step-up conversation much easier.
What we'd track
- Each shot, on time. Date, dose and injection site. It's the anchor for everything else, and it makes missed-dose questions easy to answer.
- Side effects by day after the shot. Nausea, constipation, heartburn, fatigue, rated simply. Four weeks of this shows your pattern.
- Protein, fiber and water. Not perfect numbers — just whether they're there most days.
- Weight, a few times a week. Look at the line by week four, not single mornings.
- Questions for week four. Write them down as they come up.
Holt reminds you on shot day, with a lock-screen Live Activity, and suggests the next injection site in your rotation. Side effects sit against dose days, and meal photos estimate protein and fiber without weighing anything.
Start your first month in HoltAt the end of week four, the doctor-visit report gathers the month on one page, with suggested questions for your appointment. You'll walk in with a month of notes rather than a month of guesses.
See it in Holt
Real screens from the app — the same places you’ll log, review and share.

Medication level and next dose 
Weight history 
A report for your next appointment
Frequently asked questions
Is it normal to feel nothing in the first week?
Many people notice little at the starting dose, and some notice a lot. The labels describe the starting dose as a way to begin treatment, so how you feel in week one isn't a verdict on the medicine.
What if I miss a dose in the first month?
Follow your brand's missed-dose rule and tell your prescriber. Mounjaro and Zepbound allow up to 4 days, Ozempic 5 days, and Wegovy injection says take it if the next dose is more than 2 days away.
Will I step up a dose after exactly 4 weeks?
That's the labels' usual rhythm, but your prescriber can keep you where you are longer. The Wegovy label says delaying a step by 4 weeks can be considered if a dose isn't tolerated.
Should I change my shot day once I've started?
You can if needed, within each label's rules. The Mounjaro and Zepbound labels say keep at least 3 days between doses; ask your pharmacist about yours.
Sources
- Wegovy (semaglutide) injection and tablets — Prescribing Information — U.S. Food and Drug Administration
- Ozempic (semaglutide) injection — Prescribing Information — U.S. Food and Drug Administration
- Zepbound (tirzepatide) injection — Prescribing Information — U.S. Food and Drug Administration
- Mounjaro (tirzepatide) injection — Prescribing Information — U.S. Food and Drug Administration
- Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory — Obesity (Silver Spring), 2025
Keep reading
- Moving Up a DoseWhy GLP-1 doses start low and step up every few weeks, what the Wegovy and Zepbound labels say about escalation, and what to note in the days after each step.
- GLP-1 Side EffectsThe most common GLP-1 side effects for semaglutide and tirzepatide, when they tend to appear, which warning signs need a doctor, and how tracking helps.
- GLP-1 Injection SitesWhere to inject a GLP-1 like Wegovy or Zepbound, what the labels say about rotating sites, and a simple way to keep track of where you injected last.
- GLP-1 Tracker AppHolt is a GLP-1 tracker app for iPhone. Log shots and pills, meals, protein, side effects, weight and water, and see how your dose day shapes your week.